Clin2
NCT07279714Possibly a fitCompleted

Fisetin for mild Alzheimer's disease

Alzheimer s DiseaseAlzheimer DementiaAlzheimer Dementia (AD)Alzheimer DiseaseMild Cognitive DisorderNeurocognitive Disorders, MildNeurocognitive Disorder

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests whether a supplement called fisetin can help people with mild Alzheimer's disease or mild cognitive impairment. Fisetin is a natural compound found in fruits and vegetables that may reduce aging-related changes in the body.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
5 people
Ages
60 years and older
Study type
Interventional

Who can take part

  • You have mild memory problems from Alzheimer's disease or mild Alzheimer's dementia.
  • Your memory and thinking test score (MoCA) is 11 or higher.
  • You have been on stable doses of psychiatric or memory medications for a while.
  • You are not taking blood thinners, cancer drugs, seizure drugs, or other medicines that might interact with fisetin.
  • You have not used any senolytic supplements, antioxidant supplements, or natural health products in the past month.
  • You do not have active depression, suicidal thoughts, psychosis, or other brain disorders like stroke or Parkinson's that affect memory.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06362707Recruiting· Phase 2
Fasudil trial for early Alzheimer's disease

This trial tests a medication called fasudil to see if it can help people with early Alzheimer's disease. It is for people who have early symptoms (mild cognitive impairment or mild dementia) and have biomarker evidence of Alzheimer's in their brain.

Tromsø, Nordland
NCT06639282Recruiting· Phase 2
Testing siponimod for mild Alzheimer's dementia

This study tests if a medicine called siponimod, already used for multiple sclerosis, can help people with mild Alzheimer's dementia. You will take a pill daily and be monitored closely for safety and cognitive changes.

Phoenix, Arizona
NCT06619613Recruiting· Phase 1
Study of CM383 for early Alzheimer's disease

This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.

Hefei
NCT07195318Recruiting
Fisetin supplement study for healthy aging

This study tests whether a natural supplement called fisetin can help people age more healthily. It is for Danish-speaking adults aged 50 and older who are not taking certain other supplements or medications.

Hvidovre
NCT03675724Enrolling by invitation· Phase 2
Fisetin for frailty and inflammation in older adults

This trial studies whether fisetin, a supplement-like drug, can reduce frailty and inflammation in people age 70 and older. It may help improve health measures related to aging, but you must meet several safety and medication rules to join.

Rochester, Minnesota
NCT06431932Recruiting· Phase 1/Phase 2
Fisetin for healthy and older adults with multiple conditions

This trial tests a pill called fisetin, which may help clear aging cells from the body. It is studying two groups: healthy younger adults and older adults with multiple health problems who have recently been in the hospital.

Hvidovre

Hear when a new Alzheimer s Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.